CareLit · DOI-Nachweis · Aktuelle Neurologie
Adjuvant chemotherapy with temozolomide and liposomal doxorubicine in the first-line therapy of patients with glioblastoma – a phase-II trial
DOI 10.1055/s-2004-833334
Bibliografische Angaben
Nachweis in CareLit
Autor:innenP Hau, T Jauch, B Hirschmann, E Drechsel, O Grauer, H Koch, C Wismeth, A Steinbrecher, U Bogdahn
ZeitschriftAktuelle Neurologie
Ausgabe09/2004
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Temozolomide (Temodar) recently showed promising results in the first-line therapy of glioblastoma(Stupp R, 2002). Pegylated liposomal doxorubicin (Caelyx) was successfully evaluated in patients with recurrent high-grade glioma (Fabel K, 2001; Hau P, 2002). Therefore, a combination of both agents seems promising. Here, we update data on a pilot phase II-trial using this regimen. Methods: We initiated a c…
Zitieren
Zitierempfehlung
P Hau, T Jauch, B Hirschmann, E Drechsel, O Grauer, H Koch, C Wismeth, A Steinbrecher, U Bogdahn (2004) Adjuvant chemotherapy with temozolomide and liposomal doxorubicine in the first-line therapy of patients with glioblastoma – a phase-II trial. Aktuelle Neurologie (09). https://doi.org/10.1055/s-2004-833334
Mit CareLit weiterarbeiten